Potential for Gut Peptide-Based Therapy in Postprandial Hypotension

被引:18
作者
Borg, Malcolm J. [1 ,2 ]
Xie, Cong [1 ,2 ]
Rayner, Christopher K. [1 ,2 ]
Horowitz, Michael [1 ,2 ,3 ]
Jones, Karen L. [1 ,2 ,3 ]
Wu, Tongzhi [1 ,2 ,3 ]
机构
[1] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA 5000, Australia
[3] Royal Adelaide Hosp, Endocrine & Metab Unit, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
postprandial hypotension; glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; somatostatin; diabetes mellitus; autonomic failure; GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; INTRADUODENAL GLUCOSE-INFUSION; ANALOG OCTREOTIDE SMS-201-995; SPLANCHNIC BLOOD-FLOW; HEART-RATE RESPONSES; ORAL GLUCOSE; ORTHOSTATIC HYPOTENSION; INCRETIN HORMONE; GLYCEMIC RESPONSES;
D O I
10.3390/nu13082826
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Postprandial hypotension (PPH) is an important and under-recognised disorder resulting from inadequate compensatory cardiovascular responses to meal-induced splanchnic blood pooling. Current approaches to management are suboptimal. Recent studies have established that the cardiovascular response to a meal is modulated profoundly by gastrointestinal factors, including the type and caloric content of ingested meals, rate of gastric emptying, and small intestinal transit and absorption of nutrients. The small intestine represents the major site of nutrient-gut interactions and associated neurohormonal responses, including secretion of glucagon-like peptide-1, glucose-dependent insulinotropic peptide and somatostatin, which exert pleotropic actions relevant to the postprandial haemodynamic profile. This review summarises knowledge relating to the role of these gut peptides in the cardiovascular response to a meal and their potential application to the management of PPH.
引用
收藏
页数:14
相关论文
共 90 条
  • [1] Alam M, 1995, J HYPERTENS, V13, P1664
  • [2] Armstrong E, 1991, Clin Auton Res, V1, P135, DOI 10.1007/BF01826210
  • [3] Association of postprandial hypotension with incidence of falls, syncope, coronary events, stroke, and total mortality at 29-month follow-up in 499 older nursing home residents
    Aronow, WS
    Ahn, C
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1051 - 1053
  • [4] The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors
    Avogaro, Angelo
    Fadini, Gian Paolo
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (08) : 1686 - 1695
  • [5] Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes
    Bahne, Emilie
    Sun, Emily W. L.
    Young, Richard L.
    Hansen, Morten
    Sonne, David P.
    Hansen, Jakob S.
    Rohde, Ulrich
    Liou, Alice P.
    Jackson, Margaret L.
    de Fontgalland, Dayan
    Rabbitt, Philippa
    Hollington, Paul
    Sposato, Luigi
    Due, Steven
    Wattchow, David A.
    Rehfeld, Jens F.
    Holst, Jens J.
    Keating, Damien J.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. JCI INSIGHT, 2018, 3 (23)
  • [6] Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin
    Bahne, Emilie
    Hansen, Morten
    Bronden, Andreas
    Sonne, David P.
    Vilsboll, Tina
    Knop, Filip K.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (10) : 955 - 961
  • [7] Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans
    Bharucha, Adil E.
    Charkoudian, Nisha
    Andrews, Christopher N.
    Camilleri, Michael
    Sletten, David
    Zinsmeister, Alan R.
    Low, Phillip A.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 295 (03) : R874 - R880
  • [8] Gastrointestinal Mechanisms Underlying the Cardiovascular Effect of Metformin
    Borg, Malcolm J.
    Rayner, Christopher K.
    Jones, Karen L.
    Horowitz, Michael
    Xie, Cong
    Wu, Tongzhi
    [J]. PHARMACEUTICALS, 2020, 13 (11) : 1 - 14
  • [9] Metformin attenuates the postprandial fall in blood pressure in type 2 diabetes
    Borg, Malcolm J.
    Jones, Karen L.
    Sun, Zilin
    Horowitz, Michael
    Rayner, Christopher K.
    Wu, Tongzhi
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (05) : 1251 - 1254
  • [10] HYPOTHALAMIC POLYPEPTIDE THAT INHIBITS SECRETION OF IMMUNOREACTIVE PITUITARY GROWTH-HORMONE
    BRAZEAU, P
    VALE, W
    BURGUS, R
    LING, N
    BUTCHER, M
    RIVIER, J
    GUILLEMIN, R
    [J]. SCIENCE, 1973, 179 (4068) : 77 - 79